《2020年万古霉素共识建议的有效性及实际应用的进一步指导》 - Suppr

Validity of 2020 vancomycin consensus recommendations and further guidance for practical application.

作者信息

Rybak Michael J, Le Jennifer, Lodise Thomas P, Levine Donald P, Bradley John S, Liu Catherine, Mueller Bruce A, Pai Manjunath P, Beringer Annie-Wong, Rodvold Keith A, Maples Holly D

机构信息

Anti-Infective Research Laboratory Department of Pharmacy Practice Eugene Applebaum College of Pharmacy & Health Sciences Wayne State University Detroit, MI, USA.

School of Medicine Wayne State University Detroit, MI, USA.

出版信息

Am J Health Syst Pharm. 2021 Jul 22;78(15):1364-1367. doi: 10.1093/ajhp/zxab123.

DOI:10.1093/ajhp/zxab123

PMID:33764403

Abstract

摘要

相似文献

Validity of 2020 vancomycin consensus recommendations and further guidance for practical application.《2020年万古霉素共识建议的有效性及实际应用的进一步指导》

Am J Health Syst Pharm. 2021 Jul 22;78(15):1364-1367. doi: 10.1093/ajhp/zxab123.

Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First.万古霉素曲线下面积指导剂量和监测成人和儿童疑似或确诊严重耐甲氧西林金黄色葡萄球菌感染患者：把我们患者的安全放在首位。

Clin Infect Dis. 2021 May 4;72(9):1497-1501. doi: 10.1093/cid/ciaa1744.

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会修订的共识指南及综述

Clin Infect Dis. 2020 Sep 12;71(6):1361-1364. doi: 10.1093/cid/ciaa303.

Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant Bacteremia.万古霉素药时曲线下面积给药与谷浓度目标值给药在肥胖与非肥胖耐甲氧西林金黄色葡萄球菌菌血症患者中的比较。

Ann Pharmacother. 2020 Jul;54(7):644-651. doi: 10.1177/1060028019897100. Epub 2019 Dec 30.

Establishment of an AUC Threshold for Nephrotoxicity Is a Step towards Individualized Vancomycin Dosing for Methicillin-Resistant Staphylococcus aureus Bacteremia.建立肾毒性的AUC阈值是迈向耐甲氧西林金黄色葡萄球菌菌血症个体化万古霉素给药的一步。

Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02535-16. Print 2017 May.

Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?平衡万古霉素的疗效与肾毒性：我们应该以谷浓度还是AUC/MIC为目标？

Paediatr Drugs. 2015 Apr;17(2):97-103. doi: 10.1007/s40272-015-0117-5.

Detection of heterogeneous vancomycin-intermediate : A preliminary report from south India.印度南部地区异质性万古霉素中介的检测：初步报告。

Indian J Med Res. 2019 Aug;150(2):194-198. doi: 10.4103/ijmr.IJMR_1976_17.

Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.达托霉素与万古霉素治疗耐甲氧西林金黄色葡萄球菌血流感染合并高万古霉素最低抑菌浓度：一项病例对照研究。

Clin Infect Dis. 2012 Jan 1;54(1):51-8. doi: 10.1093/cid/cir764. Epub 2011 Nov 21.

Innovative approaches to optimizing the delivery of vancomycin in individual patients.优化个体化患者万古霉素给药的创新方法。

Adv Drug Deliv Rev. 2014 Nov 20;77:50-7. doi: 10.1016/j.addr.2014.05.016. Epub 2014 Jun 5.

Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.万古霉素暴露对耐甲氧西林金黄色葡萄球菌菌血症患者结局的影响：支持共识指南建议的目标。

Clin Infect Dis. 2011 Apr 15;52(8):975-81. doi: 10.1093/cid/cir124.

引用本文的文献

Influence of renal function and daptomycin dose on clinical effectiveness and adverse events in Japanese pediatric patients: A multicenter retrospective observational study.肾功能和达托霉素剂量对日本儿科患者临床疗效及不良事件的影响：一项多中心回顾性观察研究。

PLoS One. 2025 Jul 17;20(7):e0327993. doi: 10.1371/journal.pone.0327993. eCollection 2025.

Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis.比较耐甲氧西林金黄色葡萄球菌（MRSA）血流感染患者使用达托霉素与万古霉素的疗效：系统文献回顾和荟萃分析。

PLoS One. 2024 Feb 21;19(2):e0293423. doi: 10.1371/journal.pone.0293423. eCollection 2024.

Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients.实施万古霉素群体药代动力学模型：一款用于危重症患者个体化抗生素治疗的应用程序。

Antibiotics (Basel). 2023 Feb 2;12(2):301. doi: 10.3390/antibiotics12020301.

Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC).用于测定24小时曲线下面积（AUC）的万古霉素配对测量值的特征与计算

Pract Lab Med. 2023 Jan 28;34:e00310. doi: 10.1016/j.plabm.2023.e00310. eCollection 2023 Mar.

A GC-MS-based untargeted metabolomics approach for comprehensive metabolic profiling of vancomycin-induced toxicity in mice.一种基于气相色谱-质谱联用的非靶向代谢组学方法，用于全面分析万古霉素诱导的小鼠毒性的代谢谱。

Heliyon. 2022 Jul 6;8(7):e09869. doi: 10.1016/j.heliyon.2022.e09869. eCollection 2022 Jul.

Approaching 65 Years: Is It Time to Consider Retirement of Vancomycin for Treating Methicillin-Resistant Endovascular Infections?步入65岁：是时候考虑停用万古霉素治疗耐甲氧西林血管内感染了吗？

Open Forum Infect Dis. 2022 Apr 9;9(5):ofac137. doi: 10.1093/ofid/ofac137. eCollection 2022 May.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Validity of 2020 vancomycin consensus recommendations and further guidance for practical application.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献